Attached files
| file | filename |
|---|---|
| S-1 - FORM S-1 - Benitec Biopharma Inc. | d11440ds1.htm |
| EX-23.1 - EX-23.1 - Benitec Biopharma Inc. | d11440dex231.htm |
| EX-21.1 - EX-21.1 - Benitec Biopharma Inc. | d11440dex211.htm |
| EX-10.9 - EX-10.9 - Benitec Biopharma Inc. | d11440dex109.htm |
| EX-10.4 - EX-10.4 - Benitec Biopharma Inc. | d11440dex104.htm |
| EX-10.3 - EX-10.3 - Benitec Biopharma Inc. | d11440dex103.htm |
Exhibit 16.1
August 14, 2020
| US Securities and Exchange Commission Office of the Chief Accountant 100 F Street, NE Washington, DC 20549 |
| Re: Benitec Biopharma Inc |
| File No. 001-39267 |
Dear Sir or Madam:
We have read the disclosure as it appears under the caption “Change in Auditor” in Form S-1 of Benitec Biopharma Inc. dated August 14, 2020 and are in agreement with the statements contained solely as it relates to our Firm.
Very truly yours,
/s/ GRANT THORNTON AUDIT PTY LTD
Sydney, NSW Australia
August 14, 2020